Lanosterol biosynthesis pathway in GtoPdb v.2023.1

  • Benson H
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Lanosterol is a precursor for cholesterol, which is synthesized primarily in the liver in a pathway often described as the mevalonate or HMG-CoA reductase pathway. The first two steps (formation of acetoacetyl CoA and the mitochondrial generation of (S)-3-hydroxy-3-methylglutaryl-CoA) are also associated with oxidation of fatty acids.

Cite

CITATION STYLE

APA

Benson, H. E. (2023). Lanosterol biosynthesis pathway in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). https://doi.org/10.2218/gtopdb/f104/2023.1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free